Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cryo Cell International (CCEL) Shares Outstanding (Diluted Average) (2018 - 2020)

Cryo Cell International's Shares Outstanding (Diluted Average) history spans 7 years, with the latest figure at $8.1 million for Q2 2020.

  • Quarterly results put Shares Outstanding (Diluted Average) at $8.1 million for Q2 2020, down 3.68% from a year ago — trailing twelve months through May 2020 was $8.1 million (down 3.68% YoY), and the annual figure for FY2019 was $8.4 million, up 12.72%.
  • Shares Outstanding (Diluted Average) for Q2 2020 was $8.1 million at Cryo Cell International, roughly flat from $8.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $8.4 million in Q3 2019 to a low of $7.5 million in Q4 2018.
  • The 3-year median for Shares Outstanding (Diluted Average) is $8.4 million (2018), against an average of $8.2 million.
  • The sharpest move saw Shares Outstanding (Diluted Average) grew 12.72% in 2019, then decreased 3.68% in 2020.
  • Year by year, Shares Outstanding (Diluted Average) stood at $7.5 million in 2018, then grew by 12.72% to $8.4 million in 2019, then decreased by 3.57% to $8.1 million in 2020.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $8.1 million, $8.1 million, and $8.4 million for Q2 2020, Q1 2020, and Q4 2019 respectively.